NeuroPace (NPCE) Amortization of Deferred Charges (2020 - 2026)
NeuroPace (NPCE) posted Amortization of Deferred Charges of $100000.0 for Q2 2026, up 47.06% on a QoQ basis from $68000.0 in Q1 2026, and little changed year-over-year from $100000.0 in Q2 2025.
Powered by 
Analysis
NeuroPace (NPCE) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
NeuroPace has reported Amortization of Deferred Charges for 7 years, with the latest figure at $100000.0 in Q2 2026.
- On a quarterly basis, Amortization of Deferred Charges changed 0.0% year-over-year to $100000.0 in Q2 2026; TTM through Jun 2026 was $331000.0, a 11.07% increase from a year earlier, with the FY2025 full-year figure at $237000.0, up 3.95% from the prior year.
- Amortization of Deferred Charges was $100000.0 for Q2 2026 at NeuroPace, up from $68000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $100000.0 in Q2 2022, with the low at $49000.0 in Q4 2024.
- Average Amortization of Deferred Charges over 5 years is $82222.2, with a median of $89000.0 recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: Amortization of Deferred Charges plunged 37.18% in 2025, then surged 38.78% in 2026.
- Over 5 years, Amortization of Deferred Charges stood at $66000.0 in 2022, then climbed by 15.15% to $76000.0 in 2023, then tumbled by 35.53% to $49000.0 in 2024, then climbed by 28.57% to $63000.0 in 2025, then surged by 58.73% to $100000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $100000.0 (Q2 2026), $68000.0 (Q1 2026), and $63000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | 68,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 78,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 64,000.00 |
| Dec 31, 2022 | 66,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 67,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 100,000.00 |